Citi Pharma Limited (PSX:CPHL)
Pakistan · Delayed Price · Currency is PKR 91.22
+0.55 (0.61%)
At close: Oct 21, 2025
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 20.84 billion as of October 22, 2025. Its market cap has increased by 145.81% in one year.
Market Cap
20.84B
Enterprise Value
22.20B
Revenue
13.15B
Ranking
n/a
PE Ratio
23.39
Stock Price
91.22
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 20.84B, an increase of 191.69%. That is a compound annual growth rate of 28.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 20.84B | 33.93% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
| Jul 9, 2021 | 7.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 136.41B |
| Abbott Laboratories (Pakistan) | 117.36B |
| The Searle Company | 60.79B |
| Highnoon Laboratories | 60.44B |
| AGP Limited | 55.44B |
| Shifa International Hospitals | 34.11B |
| Ferozsons Laboratories | 18.28B |
| Macter International | 16.71B |